Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc.

AUPH
Aurinia Pharmaceuticals Inc.US flagNASDAQ Global Market
16.26
USD
-0.33
- -
2.09BMarket Cap

Aurinia Pharmaceuticals Inc. (AUPH) Stock Split History

Learn about Aurinia Pharmaceuticals Inc.'s most recent 1-for-50 basis stock split on October 23, 2013. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Aurinia Pharmaceuticals Inc.'s most recent stock split

Split Date: 2013-10-23
Split Ratio: 1:50
Price Before Split: N/A
Price After Split: N/A

Developer API

Get AUPH split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/AUPH

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 50.00 times fewer shares (a 1:50 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Aurinia Pharmaceuticals Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2013-10-231:50YesN/AN/A

About Aurinia Pharmaceuticals Inc.

Company overview and industry information

Aurinia Pharmaceuticals Inc. (AUPH) operates in the Biotechnology industry. The recent 1-for-50 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Aurinia Pharmaceuticals Inc. Summary

Last updated: 7/10/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.